ResearcherQiqihar Medical UniversityNo recent work listed
Guiqiang Qi
Matched on ORCID iD 0000-0001-6920-8676; OpenAlex author ID A5007232789. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2023: 2 papers
Papers 2
- A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) fo… Co-author DOI 10.2147/ijn.s436253↗
- cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1-T2 Dual-Modal MRI and DTX Delivery. First author DOI 10.3390/molecules28166134↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Liguo Hao · 2 shared papers, 2023 · strength 0.38
- Paper A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxoru… DOI 10.2147/ijn.s436253↗
- Paper cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1-T2 Dual-Modal… DOI 10.3390/molecules28166134↗
- Shengchao Wang · 2 shared papers, 2023 · strength 0.38
- Paper A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxoru… DOI 10.2147/ijn.s436253↗
- Paper cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1-T2 Dual-Modal… DOI 10.3390/molecules28166134↗
- Guangyue Shi · 2 shared papers, 2023 · strength 0.38
- Paper A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxoru… DOI 10.2147/ijn.s436253↗
- Paper cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1-T2 Dual-Modal… DOI 10.3390/molecules28166134↗
- Na Li · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.